Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
special purpose acquisition company
Pharma
Scilex's Semnur looks to go public through $2.5B SPAC deal
Semnur Pharmaceuticals is following in its parent company Scilex's footsteps with a special purpose acquisition company merger.
Zoey Becker
Sep 3, 2024 4:35pm
Cognos strikes SPAC merger to fund implantable drug delivery R&D
Jan 10, 2023 10:35am
TriSalus inks SPAC merger to fund infusion tech cancer trials
Nov 15, 2022 10:20am
A biomanufacturing-minded SPAC has broken cover in Europe
May 9, 2022 1:48pm
